Journals / Türk Geriatri Dergisi / 2004 / Cilt: 7 - Sayı: 3

Ischemic stroke accompanying scleroderma

Skleroderma ve iskemik inme birlikteliği

Pages
173–177
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The patient with severe disphagia and died because of aspiration pneumonia.Clinical and laboratory findings of anticardiolipin antibody (+) patient were reviewed as related with central nervous system involvement of scleroderma.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Progressive systemic sclerosis (PSS) is a generalized connective tissue disease, charactrised by inflammatory, vascular and fibrotic changes of skin and a variety of internal organs.
📊
Key Findings & Data:Neurologic manifestations in PSS, which consisting mainly of muscle changes and peripheral neuropathy, have been reported in only 0.8% to 5.6% of patients.
💡
Conclusion & Impact:The patient with severe disphagia and died because of aspiration pneumonia.Clinical and laboratory findings of anticardiolipin antibody (+) patient were reviewed as related with central nervous system involvement of scleroderma.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Progressive systemic sclerosis (PSS) is a generalized connective tissue disease, charactrised by inflammatory, vascular and fibrotic changes of skin and a variety of internal organs. Neurologic manifestations in PSS, which consisting mainly of muscle changes and peripheral neuropathy, have been reported in only 0.8% to 5.6% of patients. Central nervous system involvement is rare, with few case reports of cerebral arteritis.A 52 year old woman was admitted with aphasia and right hemiparesis to emergency unit. She had been treated for Scleroderma since 1996 and hev clinical and laboratory findings confirmed to progressive systemic sclerosis. Right peripheral facial paralysis and right hemiparesis were established in neurological examination. While on the early period of patient’s cranial computerized tomography (CT) there was a hypodens area at the left temporoparietal region because of to ischemia, on control cranial MRI, left frontotemporoparietal infarct was established. Besides, there were ischemic gliotic lesions at left centrum semiovale. The etiology of thrombosis at anticardiolipin antibody (+) patient was thaught to be related to scleroderma. The patient with severe disphagia and died because of aspiration pneumonia.Clinical and laboratory findings of anticardiolipin antibody (+) patient were reviewed as related with central nervous system involvement of scleroderma.

Özet

Progresif sistemik skleroz, deri ve çeşitli organlarda inflamatuar, vasküler ve fibrotik değişikliklerle karakterize jeneralize bir bağ doku hastalığıdır. Nörolojik belirtiler bu hastalıkta daha çok kas tutulumu ve periferik nöropati olmak üzere % 0,8ı5,6 oranında bildirilmiştir. Santral sinir sistemi tutulumu nadirdir ve az sayıda serebral arterit vakası anımlanmıştır.Elli iki yaşındaki kadın hasta, konuşamama ve sağ tarafında güçsüzlük yakınması ile acil servise kabul edildi. Hastanın yedi yıldan beri skleroderma tanısı ile tedavi aldığı öğrenildi. Klinik ve laboratuar bulguları, progresif sistemik skleroz ile uyumluydu. Nörolojik muayenede sağ periferik fasial paralizi, sağ hemiparezi tespit edildi. Hastanın erken dönemde çekilen bilgisayarlı beyin tomografisinde sol temporoparietal bölgede iskemi ile uyumlu hafif hipodens görünüm mevcutken, kontrol amaçlı çekilen kranial MRI tetkikinde sol frontotemporopaietal yerleşimli infarkt tespit edildi. Ayrıca sol sentrum semiovalede iskemik gliotik lezyonlar mevcuttur Antikardiolipin Ab (+) olan hastada tromboz etyolojisinde sklerodermaya bağlı mekanizmaların olabileceği düşünüldü. İleri derecede yutma güçlüğü olan hasta, aspirasyon pnömonisi ile kaybedildi.Antikardiolipin Ab (+) olan hastanın klinik ve laboratuar bulguları, sklerodermanın santral sinir sistemi tutulumu yönünden gözden geçirildi.

🔖

Cite This Article

ÖZTÜRK, Ş., TİTİZ, A. P. (2022). Ischemic stroke accompanying scleroderma. Türk Geriatri Dergisi, Cilt: 7 - Sayı: 3, 173–177. https://ajindex.com/articles/624366

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Krieg T, Meurer M. Systemic scleroderma: clinical and pathophysiologic aspects. J Am Acad Dermatol. 1988; 18: 457-481 2. Gordon RM, Silverstein A. Neurologic manifestations in progressive systemic sclerosis. Arch Neurol. 1970; 22: 126-134 3. Tuffanelli D, Winkelmann RK. Systemic scleroderma: a clinical study of 727 cases. Arch Dermatol. 1961; 84: 359-371 4. Lee P, Bruni J, Sukenik S. Neurological manifestations in systemic sclerosis (scleroderma). J Rheumatol. 1984; 11: 480-483 5. Isenberg D. Myositis in other connective tissue disorders. Clin Rheum Dis. 1984; 10: 151-174 6. Clements PJ, Furst DE, Campion DS, et al. Muscle disease in progressive systemic sclerosis. Athritis Rheum. 1978; 21: 62-71 7. Sigal LH. The neurologic presentation of vasculitic and rheumatologic syndromes: a review. Medicine. 1987; 66: 157-179 8. Dierckx RA, Aichner F, Gerstenbrand F, Fritsch P. Progressive systemic sclerosis and nervous system involvement: a review of 14 cases. Eur Neurol. 1987; 26: 134-140 9. Estey E, Liebermann A, Pinto R, Meltzer M, Ransohoff J. Cerebral arteritis in scleroderma. Stroke. 1979; 10: 595-597 10. Brown JJ, Murphy MJ. Transverse myelopathy in progressive systemic sclerosis. Ann Neurol. 1985; 17: 615-617 11. Ishida K, Kamata T, Tsukagoshi H, Tanizaki Y. Progressive systemic sclerosis with CNS vasculitis and cyclosporin A therapy (Letters to the editor). Journal of Neurology, Neurosurgery and Psychiatry 1993; 56: 720 12. Pathak R, Gabor AJ. Scleroderma and central nervous system vasculitis. Stroke 1991; 22: 410-413 13. Piper WN, Helwig EB. Progressive systemic sclerosis. Arch Dermatol. 1955; 72: 535-546 14. Nishida A, Kaiya H, Uematsu M, Maeda M, Mori S, Wakabayashi S. Transient global amnesia and Raynaud's phenomenon in scleroderma. Acta Neurol Scand. 1990; 81: 550-552 15. D'Angelo WA, Fries JF, Masi AT, Shulman LE. Pathologic observations in systemic sclerosis (scleroderma). Am J Med. 1969; 46: 428-440 16. Nobili F, Cutolo M, Sulli A, Castaldi A, Sardanelli F, Accardo S, Rosadini G, Rodriguez G. Impaired quantitative cerebral blood flow in scleroderma patients. J Neurol Sci. 1997; 152: 63-71 17. Lee JE, Haynes JM. Carotid endarteritis and cerebral infarction due to scleroderma. Neurology. 1967; 17: 18-22 18. Lotz BP, Engel AG, Nishino H, Stevens JC, Litchy WJ. Inclusion body myositis: observations in 40 patients. Brain. 1989; 112: 727- 747. 19. Richter RB. Peripheral neuropathy and connective tissue disease. J Neuropathol Exp Neurol. 1954; 13: 168-